MPL Baltimore mutation and thrombocytosis: Case report and literature review

Journal of Pediatric Hematology/Oncology

Volumn 35, Issue 3, 2013, Pages

  Shkalim Zemer, Vered ^a,b   Dgany, Orly ^b   Krasnov, Tanya ^b   Yacobovich, Joanne ^a,b   Tamary, Hannah ^a,b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Children; MPL Baltimore; Thrombocytosis

Indexed keywords

ASPARAGINE; C MPL RECEPTOR; GENOMIC DNA; IRON POLYMALTOSE; LYSINE; RECEPTOR; THROMBOPOIETIN; UNCLASSIFIED DRUG;

BLOOD SMEAR; C MPL GENE; CASE REPORT; CHILD; DNA DETERMINATION; ETHIOPIAN JEWISH; ETHNIC GROUP; EXON; FAMILY ASSESSMENT; GENE MUTATION; HOMOZYGOSITY; HUMAN; HUMAN CELL; INFANT; IRON DEFICIENCY ANEMIA; MALE; MUTATIONAL ANALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN MODIFICATION; RECEPTOR GENE; REVIEW; THROMBOCYTE COUNT; THROMBOCYTOSIS;

HOMOZYGOTE; HUMANS; INFANT; MALE; MUTATION; RECEPTORS, THROMBOPOIETIN; REVIEW LITERATURE AS TOPIC; THROMBOCYTOSIS;

EID: 84876120392     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318286d54c     Document Type: Review

References (18)

1. Teofili L, Larocca LM. Advances in understanding the pathogenesis of familial thrombocythaemia. Br J Haematol. 2011;152: 701-712.
2. Geddis AE. Megakaryopoiesis. Semin Hematol. 2010;47: 212-219.
3. Cazzola M. Molecular basis of thrombocytosis. Haematologica. 2008;93: 646-648.
4. Dame C, Sutor AH. Primary and secondary thrombocytosis in childhood. Br J Haematol. 2005;129: 165-177.
5. Teofili L, Foa R, Giona F, et al. Childhood polycythemia vera and essential thrombocythmia: dose their pathogenesis overlap with that of adult patients? Hematologica. 2008;93: 169-172.
6. Harrison CN, Bareford D, Butt N, et al. British Committee for Standards in Haematology. Guideline for investigation and management of adults and children presenting with a thrombocytosis. Br J Haematol. 2010;149: 352-375.
7. Dror Y, Blanchette VS. Essential thrombocythaemia in children. Br J Haematol. 1999;107: 691-698.
8. Hasle H. Incidence of essential thrombocythaemia in children. Br J Haematol. 2000;110: 751.
9. Beer PA, Erber WN, Campbell PJ, et al. How I treat essential thrombocythemia. Blood. 2011;117: 1472-1482.
10. Moliterno AR, Williams DM, Gutierrez-Alamillo LI, et al. MPL Baltimore: a thrombopoietin receptor polymorphism associated with thrombocytosis. Proc Natl Acad Sci USA. 2004;101: 11444-11447.
11. Wiestner A, Schlemper RJ, van der Maas AP, et al. An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia. Nat Genet. 1998;18: 49-52.
12. Kondo T, Okabe M, Sanada M, et al. Familial essential thrombocythemia associated with one-base deletion in the 50- untranslated region of the thrombopoietin gene. Blood. 1998; 92: 1091-1096.
13. Ghilardi N, Skoda RC. A single-base deletion in the thrombopoietin (TPO) gene causes familial essential thrombocythemia through a mechanism of more efficient translation of TPO mRNA. Blood. 1999;94: 1480-1482.
14. Ghilardi N, Wiestner A, Kikuchi M, et al. Hereditary thrombocythaemia in a Japanese family is caused by a novel point mutation in the thrombopoietin gene. Br J Haematol. 1999;107: 310-316.
15. Jorgensen MJ, Raskind WH, Wolff JF, et al. Familial thrombocytosis associated with overproduction of thrombopoietin due to novel splice donor site mutation [abstract]. Blood. 1998;92: 205. Abstract #834.
16. Liu K, Martini M, Rocca B, et al. Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia. Haematologica. 2009;94: 1368-1374.
17. El-Harith el-HA, Roesl C, Ballmaier M, et al. Familial thrombocytosis caused by the novel germ-line mutation p.Pro106Leu in the MPL gene. Br J Haematol. 2009;144: 185-194.
18. Standen G, Clench T. Rapid detection of MPL Baltimore using LightCycler technology and melting curve analysis. Br J Haematol. 2008;140: 714-716.